With extensive expertise in the technology and healthcare sectors, the fund manager has successfully led over 50 investment deals across North America and Europe. Emphasizing a data-driven approach, they focus primarily on early to growth-stage investments, leveraging analytical insights to identify high-potential opportunities. The portfolio showcases notable exits, including several within the software and biotechnology fields, reflecting a strategic operation that prioritizes innovation and scalability. Their experience is underscored by a commitment to thematic investing, addressing emerging trends that shape the future market landscape.